CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues
Software and devices	$ 0	$ 4	$ 80	$ 42
Services - Consulting			0	97
Gaming	296	36	614	54
Other	1	0	8	0
Revenues	297	40	702	193
Cost of revenues
Services - Consulting			0	63
Gaming	168	118	384	138
Cost of Revenues	168	118	384	201
Gross margin	129	(78)	318	(8)
Operating expenses
General and administrative	1,411	2,798	4,211	7,037
Sales and marketing	121	26	229	92
Research and development	40	0	153	0
Operating Expenses, Total	1,572	2,824	4,593	7,129
Operating loss	(1,443)	(2,902)	(4,275)	(7,137)
Other non-operating income / (expense)
Interest and other income	2	16	7	43
Gain on sale of medical imagine patents			0	750
Change in fair value of warrants			0	(2,204)
Other Nonoperating Income (Expense)	2	16	7	(1,411)
Net loss before income taxes and non-controlling interest	(1,441)	(2,886)	(4,268)	(8,548)
Income tax benefit / (expense)	(10)	0	1	(3)
Net loss before non-controlling interest	(1,451)	(2,886)	(4,267)	(8,551)
Net loss attributable to non-controlling interest	71	232	373	379
Net loss attributable to MGT	(1,380)	(2,654)	(3,894)	(8,172)
Less
Quarterly dividend on Series A Preferred Stock	0	(1)	0	(69)
Net loss applicable to Common shareholders	$ (1,380)	$ (2,655)	$ (3,894)	$ (8,241)
Per-share data
Basic and diluted loss per share (in dollars per share)	$ (0.14)	$ (0.41)	$ (0.42)	$ (1.66)
Weighted average number of common shares outstanding (in shares)	9,685,023	6,444,850	9,175,695	4,972,829